Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe. The study,…
Read More
New study finds antidepressant drug effective in treating ‘lazy eye’ in adults
In a new study, published in Current Biology, researchers from the University of California, Irvine School of Medicine reveal how subanesthetic ketamine, which is used for pain management and as an antidepressant in humans, is effective in treating adult amblyopia,…
Read More
Scientists rescue mini retinas from eye disease via new gene therapy approach
Scientists have developed a new gene therapy approach that offers tremendous promise for one day treating an eye disease that leads to blindness and affects thousands of people across the globe. Researchers from Trinity College Dublin and University College London…
Read More
Researchers restore sight in mice by turning skin cells into light-sensing eye cells
Researchers have discovered a technique for directly reprogramming skin cells into light-sensing rod photoreceptors used for vision. The lab-made rods enabled blind mice to detect light after the cells were transplanted into the animals’ eyes. The work, funded by the…
Read More
Breakthrough technology used to discover eye damage from repeated intravitreal injections
In a first of its kind study, Mount Sinai researchers are using optimal coherence tomography angiography (OCTA) to measure potential retina damage from long-term use of intravitreal eye injections. The findings, published in the April issue of Retina, suggest that…
Read More
Teprotumumab bests placebo for active thyroid eye disease
(HealthDay)—Teprotumumab is associated with better outcomes than placebo among patients with active thyroid eye disease, according to a study published in the Jan. 23 issue of the New England Journal of Medicine. Raymond S. Douglas, M.D., Ph.D., from the Cedars-Sinai…
Read More